A1CAP vs BIOEN Comparison
Price, market cap, valuation, profitability and leverage metrics of A1CAP and BIOEN side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | A1CAP | BIOEN | Sector median |
|---|---|---|---|
| Last price (TL) | 4.31 | 9.32 | 10.30 |
| Daily change | −2.71% | −8.63% | −2.71% |
| Market cap | TRY 2.9B | TRY 4.7B | TRY 2.9B |
| P/E | 1.76 | — | 3.18 |
| P/B | 0.33 | 1.56 | 0.73 |
| Return on equity | 21.79% | −23.95% | 22.98% |
| Free float | 33.94% | 52.11% | 33.39% |
Popular comparisons
Related pages
About the A1CAP vs BIOEN comparison
Price, market cap, valuation multiples, profitability and leverage of A1CAP (A1 Capital Yatirim) and BIOEN (Biotrend Cevre ve Enerji) side by side as of Sep 28, 2026, 11:40. Of the 14 metrics compared, A1CAP leads in 11 and BIOEN leads in 3.
Highlights: Daily change: A1CAP leads (−2.71% vs −8.63%). Market cap: BIOEN leads (TRY 4.7B vs TRY 2.9B). P/B: A1CAP leads (0.33 vs 1.56). EV/EBITDA: BIOEN leads (85.99 vs −2.21). EV/Sales: BIOEN leads (7.58 vs −0.78). Gross margin: A1CAP leads (6.40% vs −7.36%). EBITDA margin (annual): A1CAP leads (15.49% vs 5.02%). Net margin (annual): A1CAP leads (5.16% vs −34.61%).
Frequently asked questions
Is A1CAP or BIOEN cheaper?
By P/E, Tie is cheaper (1.76 vs —); by P/B, A1CAP trades at the lower multiple (0.33 vs 1.56).
Which is more profitable, A1CAP or BIOEN?
Annual net margin is 5.16% for A1CAP and −34.61% for BIOEN; return on equity is 21.79% for A1CAP and −23.95% for BIOEN.
Which is more leveraged, A1CAP or BIOEN?
The leverage ratio is 67.81 for A1CAP and 71.76 for BIOEN; net debt/EBITDA is −2.70 for A1CAP and 46.35 for BIOEN. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.